• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. Little data exists about how long-term exposure to these drugs could affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to consider the benefits of taking it against the possible risks to the foetus. Doctors don't have enough data to make unambiguous recommendations but they can provide information on risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants in early pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure an accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study was not without its flaws. Most important, they were unable to separate the effects of the medication from those of the underlying disorder. That limitation makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. The researchers also did not study long-term outcomes for offspring.

The study showed that infants whose mothers had taken ADHD medication during pregnancy had a slightly higher chance of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or stopped taking their medication before or during pregnancy. This was due to central nervous system-related disorders, and the increased risk for admission was not found to be influenced by the stimulant medication was used during pregnancy.

Women who took stimulant uk adhd medication medications during pregnancy also had a higher risk of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit to both mother and child of continued treatment for the woman's disorder. Doctors should discuss with their patients about this and, if possible, help them improve coping skills which may reduce the effects of her disorder on her daily life and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors have to consider their own expertise, the experience of other physicians and the research on the topic.

The issue of possible risks to infants is difficult to determine. The research on this issue is based on observation instead of controlled studies and many of the findings are contradictory. In addition, most studies limit their analysis to live births, which may undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion: While some studies have shown an association between ADHD medications and certain birth defects however, other studies haven't established a link. Most studies show an unintended, or urlky.com slightly negative, effect. In the end an accurate risk-benefit analysis must be conducted in every case.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping adhd medication in the uk medications during pregnancy can lead to depression and feelings of isolation. In addition, a decrease in medication can affect the ability to do jobs and drive safely that are crucial aspects of a normal life for many people suffering from ADHD.

She suggests that women who are unsure whether to take the medication or stop due to pregnancy should educate family members, coworkers, and acquaintances about the condition, the effects on daily functioning, and the benefits of continuing the current treatment regimen. It can also aid in ensuring that the woman feels supported as she struggles with her decision. It is also worth noting that certain medications can pass through the placenta, so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug can be passed on to the baby.

Risk of Birth Defects

As the use and misuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) is increasing as does the concern about the possible effects of the drugs on foetuses. A study that was published in the journal Molecular Psychiatry adds to the body of information on this topic. Researchers used two massive datasets to analyze more than 4.3 million pregnant women and determine if stimulant medication use increased birth defects. Researchers found that while the risk overall is low, the first trimester ADHD medication use was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The authors of the study did not discover any connection between the use of early medications and congenital anomalies such as facial deformities or [Redirect Only] club feet. The results are in line with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications prior to the time of pregnancy. The risk was higher during the latter part of pregnancy, as many women are forced to stop taking their ADHD medication.

Women who were taking ADHD Best medication for adhd and anxiety during the first trimester were more likely require a caesarean delivery and also have an insufficient Apgar after delivery and had a baby that required breathing assistance when they were born. However the authors of the study were not able to eliminate bias due to selection by limiting the study to women who did not have any other medical issues that could have contributed to these findings.

The researchers hope their research will serve to inform the clinical decisions of physicians who treat adhd without medication adults pregnant women. They suggest that although discussing risks and benefits is important, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an option, it is not an option that is recommended due to the high incidence of depression and other mental health issues among women who are pregnant or recently post-partum. Research has also shown that women who stop taking their medication will have a difficult adjustment to life without them once the baby is born.

Nursing

It can be overwhelming becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending physician appointments, making preparations for the arrival of a child and adjusting to new household routines are often faced with a number of difficulties. As such, many women elect to continue taking their ADHD medications throughout pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medication passes through breast milk at low levels. The amount of exposure to medications can vary depending upon the dosage the medication is administered, its frequency and the time of the day. Additionally, different medications enter the baby's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn isn't fully understood.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a difficult decision for the patient, who must balance the benefits of continuing her medication against the possible dangers to the foetus. As long as more information is available, doctors can inquire about pregnant patients if they have any history of ADHD or if they plan to take medication during the perinatal stage.

Many studies have shown that women can continue taking their ADHD medication without risk during pregnancy and breast-feeding. As a result, many patients choose to do so and, in consultation with their physician, they have discovered that the benefits of maintaining their current medication far outweigh any risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be informed about treatment options and build the coping mechanisms. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a treatment plan for both mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.